© 2021 Smart + Strong. All Rights Reserved. Terms of use and Your privacy. Smart + Strong® is a registered trademark of CDM Publishing, LLC.
An HIV prevention roundup
At the center of the lawsuit is Teva Pharmaceutical, slated to sell a generic version of the HIV prevention pill PrEP next year.
Only one company will sell a version of the HIV prevention pill Truvada. When others go to market, prices will likely drop further.
Pharma sets the prices for HIV and hep C drugs very high. What happens to those prices along the supply chain?
The tablet from the South Korean company Celltrion contains tenofovir disoproxil fumarate and lamivudine.
This marks the manufacturer’s fifth generic antiretroviral launch.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.
